These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 504375)
1. "Passing off": a current legal issue in marketing of pharmaceuticals. Fink JL; Nelson AA Pharm Manage Comb Am J Pharm; 1979; 151(5):209-10. PubMed ID: 504375 [No Abstract] [Full Text] [Related]
2. Drug labeling should be kept current. Rajpal A; Reidenberg MM Clin Pharmacol Ther; 2003 Jan; 73(1):4-6. PubMed ID: 12545138 [No Abstract] [Full Text] [Related]
3. More states adopt generic substitution laws. Goldsmith LS J Leg Med (N Y); 1977 Oct; 5(10):31-2. PubMed ID: 303272 [No Abstract] [Full Text] [Related]
9. Some effects of drug laws and regulations on the practice of medicine, with particular emphasis on inflammatory bowel disease. Goldstein F Am J Gastroenterol; 1988 Oct; 83(10):1091-7. PubMed ID: 3421219 [No Abstract] [Full Text] [Related]
10. Package inserts, adverse drug reactions, and the physician's liability. Morrell MX Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773 [No Abstract] [Full Text] [Related]
11. Pros and cons of off-label promotion investigations and prosecutions. Loucks MK Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041 [No Abstract] [Full Text] [Related]
12. Who's in charge here? OSHA's/OMB's labeling standard. Schechter D Occup Health Saf; 1982 May; 51(5):21-5. PubMed ID: 7078916 [No Abstract] [Full Text] [Related]
13. Off-label or off-limits? Ratner M; Gura T Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236 [No Abstract] [Full Text] [Related]
14. Some issues related to patient package inserts. Fink JL Hosp Formul; 1979 Feb; 14(2):181-3. PubMed ID: 10240143 [No Abstract] [Full Text] [Related]
15. Drug identification by imprint. Robertson KA; Robertson WO Clin Toxicol; 1974; 7(1):83-9. PubMed ID: 4838230 [No Abstract] [Full Text] [Related]
16. The patient package insert--health care provider's friend or foe? Hirsh HL Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734 [No Abstract] [Full Text] [Related]
17. Generic vs. brand name drugs--quality, not cost, is key issue. Stetler CJ Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133 [No Abstract] [Full Text] [Related]
18. Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going? Joseph JN; Deaton D; Ehsan H; Bonanno MA J Health Life Sci Law; 2009 Jan; 2(2):73-108. PubMed ID: 19288889 [TBL] [Abstract][Full Text] [Related]
19. Pharmaceuticals: generic/ therapeutic drug substitution: year end report-2002. Floridi T; Kammer C Issue Brief Health Policy Track Serv; 2002 Dec; ():1-12. PubMed ID: 12856672 [No Abstract] [Full Text] [Related]
20. Labeling and record keeping for compounded drugs. Ballitch EJ J Am Vet Med Assoc; 1994 Jul; 205(2):249-50. PubMed ID: 7928591 [No Abstract] [Full Text] [Related] [Next] [New Search]